About BTM

A Commercial Platform Focusing On Licensing Innovative Products With Unique Market Value

Rapid development of innovative drugs will drive growth of China pharmaceutical market. BTM focus on licensing in products of unique market value with global BD networks. We will deliver innovative drugs and treatment solution into China market to meet more medical needs, and explore the China market successfully with professional commercial team.

Learn More ▶

Cover the upper part of the skin that may cause pressure sores due to the compression of the respirator, provide protection for the patient from medical devices or external harm

Learn More ▶

The unique patented technology can effectively extract high concentration pure platelet plasma, can effectively inhibit inflammation, relieve pain, promote and accelerate tissue repair

Learn More ▶

Provide long-term treatment options for osteoarthritis and sports injury

Learn More ▶

Provide long-term treatment options for osteoarthritis and sports injury

Learn More ▶

Effective treatment drug for interstitial cystitis and relieve related disease symptoms

Learn More ▶

News

202311-09

BTM Singed Exclusive Rights To Commercialize BTM101 in Mainland China,Hong Kong and Macao

In September 2023, BTM signed exclusive rights to commercialize BTM101 in Mainland China,Hong Kong and Macao, ...

More >

202305-05

Better Time Biotechnology IND APPLICATION FOR BTM002 APPROVED BY NMPA

On 28 April 2023, an Investigational New Drug application for BTM002 was approved by the National Medical Prod...

More >

202003-08

Launched Pellefeel Mask Pressure Relief Pad In China

Launched Pellefeel mask pressure relief pad in China, CR Pharma Shanghai acts as the general distributor

More >